Equities
North America
Europe
Asia
Oceania
Middle East
South America
Africa
»
More Equities
Indexes
America
DOW JONES
NASDAQ COMP
S&P 500
NASDAQ 100
TSX COMP
MEXICO IPC
BOVESPA
Index and indicators
VOLATILITY
DOLLAR INDEX
»
More Indexes
Europe
FTSE 100
DAX
CAC 40
BEL 20
ATHEX COMP
RUSLAND RTS
SMI
IBEX 35
MILANO MIB
AEX
PSI 20
POLAND WIG
Asia, Pacific
NIKKEI 225
SHANGHAI COMP
HANG SENG
KOSPI COMP
SENSEX
TAIWAN TWSE
THAILAND 50
SYDNEY ASX
Middle East
EGX 30
TELAVIV 25
Commodities
Energy
Crude Oil (WTI)
Crude Oil (BRENT)
URANIUM
Index and indicators
CRB COMMODITY
BALTIC DRY
»
More Commodities
Metals
GOLD
SILVER
PLATINUM
PALLADIUM
ALUMINIUM
COPPER
LEAD
TIN
ZINC
Agriculture
COFFEE
SUGAR
CORN
COCOA
COTTOM
WHEAT
PALM IOL
SOYBEANS
Currencies
EUR / USD
USD / JPY
GBP / USD
AUD / USD
USD / CHF
USD / CAD
»
More Currencies
News
Latest News
Markets
Commodities
Business Leaders
Most Popular News
Hot News
Finance Calendar
Economic Calendar
Companies
All News
Press Releases
Events
Corporate actions
Economy & Forex
All News
Currencies / Forex
Economic Events
Press releases
Analysis
All Analysis
Commentaries
Stock Trading Strategies
Index Analysis
Forex Analysis
Commodity Analysis
Top & Flop
Gainers & Losers
Unusual Volumes
STIM
Top / Flop RSI
Top / Flop Gaps
Top / Flop Capitalizations
Market Screener
Technical Analysis
Oversold stocks
Overbought stocks
Close to resistances
Close to supports
Accumulation phase
Most volatile stocks
Fundamentals
Top Investor Rating
Top Trading Rating
Top Consensus
Growth stocks
Yield stocks
Low valuations
Market Screener
Sectors
Finance Calendar
Calendar
Finance Calendar
Economic Calendar
4-Traders Homepage
>
Shares
>
London Stock Exchange
>
Vernalis plc
VER
GB00B3Y5L754
VERNALIS PLC
(VER)
0
Delayed London Stock Exchange -
05/17 11:35:06 am
22.5
GBp
-1.10%
04/29
VERNALIS PLC
: Holding(s) in Company
04/26
VERNALIS PLC
: Transaction of Directors
04/19
VERNALIS PLC
: Transaction by Directors
Summary
Quotes
Chart Analysis
News
Calendar
Company
Financials
Consensus
Revisions
Forum
Sector
Healthcare
Biotechnology / Pharmaceuticals
Biotechnology / Pharmaceuticals
Pharmaceuticals - Diversified
Logo
Business Summary
Vernalis plc
is a British based biotech company founded in 2003 by the merger of Vernalis Group with British Biotech in a deal valued at £90 million. The merger allowed British Biotech to ditch its historic but tarnished name.
Wikipedia
Surperformance© rating of Vernalis plc
Overall rating
In sector
In country
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
PER
-
-
-
Potential
-
-
-
Yield
-
-
-
Consensus
7 days EPS revision
-
-
-
4 months EPS revision
-
-
-
1 year EPS revision
-
-
-
4 months Revenue revision
1 year Revenue revision
More Ratings
Sector Pharmaceuticals - Diversified
Country
Trading Rating
Investor Rating
JOHNSON & JOHNSON
USA
ROCHE HOLDING LTD.
Switzerland
PFIZER INC.
USA
NOVARTIS AG
Switzerland
SANOFI
France
MERCK & CO., INC.
USA
GLAXOSMITHKLINE PLC
United Kingdom
BAYER AG
Germany
NOVO NORDISK A/S
Denmark
BRISTOL MYERS SQUIBB CO.
USA
ELI LILLY & CO.
USA
ABBOTT LABORATORIES
USA
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
ISRAEL
ALEXION PHARMACEUTICALS, INC.
USA
SHIRE PLC
United Kingdom
ACTAVIS INC
USA
DAIICHI SANKYO COMPANY, LIMITED
Japan
CHUGAI PHARMACEUTICAL CO., LTD.
Japan
MYLAN INC.
USA
UCB
Belgium
BIOMARIN PHARMACEUTICAL INC.
USA
TASLY PHARMACEUTICAL GROUP CO LTD
CHINA
TAISHO PHARMACEUTICAL HOLDINGS CO LTD
Japan
HISAMITSU PHARMACEUTICAL CO., INC.
Japan
WARNER CHILCOTT PLC
USA
Sector Pharmaceuticals - Diversified
Data source :
© 2013 Thomson Reuters
Ratings :
© 2013 Surperformance
Advertisement
Loading...
Dynamic quotes
ON
|
OFF
My Watchlist
|
My Portfolio
Copyright © 2013 Surperformance. All rights reserved.
